HIPRA is committed to providing solutions that contribute to improving the global health, of both people and animals.

Present in 40 countries with own commercial affiliates, HIPRA is a pharmaceutical multinational company focus on biologics (vaccines).

HIPRA está comprometida en aportar soluciones que contribuyan a mejorar la salud global, tanto la de las personas como la de los animales. Referentes en prevención Más de 50 años …

HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic …

Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA. Lawful basis: Performance …

Hipra Laboratories, S.A. is a Spanish pharmaceutical multinational founded in 1954. It began in the field of veterinary medicine but is also developing a vaccine against COVID-19. [1]

Global information about the BIMERVAX® COVID-19 HIPRA’s vaccine, adjuvanted recombinant protein vaccine, based on a receptor-binding domain fusion heterodimer. The approval status …

2021年9月28日 · HIPRA is a multinational pharmaceutical company focused on prevention and diagnosis for animal and human health, with a broad range of highly innovative vaccines and …

Here we present a review of the evidence base for a new COVID-19 vaccine, PHH-1V (Bimervax®; HIPRA HUMAN HEALTH S.L.U), and the results of an expert consensus. …

Discover HIPRA Building Immunity for a Healthier World HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad …